To gain more insight into the in situ expression of Hv1 in MDSCs infiltrating the LLC tumors, we performed immunofluorescence staining of LLC tumor sections using the Hv1-specific antibody validated in WB analysis. This evidence concerns the gene HVCN1 and neoplasm.